4//SEC Filing
ROWLAND LLOYD A 4
Accession 0001610717-23-000420
CIK 0001501989other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:11 PM ET
Size
4.7 KB
Accession
0001610717-23-000420
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Sale
Common Stock
2023-12-20$1.38/sh−4,077$5,629→ 97,996 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
- [F2]Includes 41,875 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001236395
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:11 PM ET
- Size
- 4.7 KB